SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 3 filers reported holding SEATTLE GENETICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Decheng Capital Management III (Cayman), LLC | 23,014 | $3,149,000 | 1.14% |
| PARTNERS CAPITAL INVESTMENT GROUP, LLP | 81,103 | $11,097,000 | 0.66% |
| NORTH STAR ASSET MANAGEMENT INC | 2,750 | $376,000 | 0.03% |
External links
This page lists SEATTLE GENETICS INC's shareholders in Q3 2022. To view SEATTLE GENETICS INC's shareholder history, click here.